BioNTech SE (BNTX) Asset Utilization Ratio (2019 - 2025)
BioNTech SE's (BNTX) quarterly Asset Utilization Ratio came in at 0.11 in Q4 2025, down 99.92% year-on-year from 144.95 in Q4 2024, and down 99.92% quarter-over-quarter from 142.72 in Q3 2025.
BioNTech SE (BNTX) Asset Utilization Ratio (2019 - 2025) Analysis & Trends
BioNTech SE has disclosed Asset Utilization Ratio across 7 years of filings, most recently posting 0.11 for Q4 2025.
- Asset Utilization Ratio for Q4 2025 came in at 0.11, down 99.92% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.11 (down 99.92% YoY), and the FY2025 annual result was 0.0, down 97.12% from the prior year.
- Asset Utilization Ratio came in at 0.11 for Q4 2025 at BioNTech SE, down from 142.72 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 105105.54 in Q1 2021 to a low of 0.11 in Q1 2024.
- The 5-year median for Asset Utilization Ratio is 0.98 (2022), against an average of 9326.08.
- Peak annual rise in Asset Utilization Ratio reached 97192769.24% in 2021, while the deepest fall reached 100.0% in 2021.
- BioNTech SE's Asset Utilization Ratio stood at 1.28 in 2021, then plunged by 38.34% to 0.79 in 2022, then tumbled by 78.7% to 0.17 in 2023, then soared by 85987.08% to 144.95 in 2024, then tumbled by 99.92% to 0.11 in 2025.
- The last three Asset Utilization Ratio figures came in at 0.11 (Q4 2025), 142.72 (Q3 2025), and 150.84 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn | 0.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.11 |
| Sep 30, 2025 | 142.72 |
| Jun 30, 2025 | 150.84 |
| Mar 31, 2025 | 152.21 |
| Dec 31, 2024 | 144.95 |
| Sep 30, 2024 | 0.13 |
| Jun 30, 2024 | 0.11 |
| Mar 31, 2024 | 0.11 |
| Dec 31, 2023 | 0.17 |
| Sep 30, 2023 | 0.28 |
| Jun 30, 2023 | 0.39 |
| Mar 31, 2023 | 0.53 |
| Dec 31, 2022 | 0.79 |
| Sep 30, 2022 | 0.90 |
| Jun 30, 2022 | 1.06 |
| Mar 31, 2022 | 1.32 |
| Dec 31, 2021 | 1.28 |
| Sep 30, 2021 | 29,626.18 |
| Jun 30, 2021 | 51,191.88 |
| Mar 31, 2021 | 105,105.54 |